Axela

Recent Finacing

Hybrid

Recent Raise

$2.8M

Axela Inc. develops multiplex molecular diagnostic analyzers measuring 100+ genes and proteins to predict, diagnose, and monitor cancers, infections, and other diseases, and commercializes tests via international laboratory partnerships.